| Literature DB >> 31499951 |
Qing Yao1, Ya-Wen Zheng2, Qing-Hua Lan2, Longfa Kou3, He-Lin Xu2, Ying-Zheng Zhao4.
Abstract
Decellularized matrix (dECM) is isolated extracellular matrix of tissues from its original inhabiting cells, which has emerged as a promising natural biomaterial for tissue engineering, aiming at support, replacement or regeneration of damaged tissues. The dECM can be easily obtained from tissues/organs of various species by adequate decellularization methods, and mimics the structure and composition of the native extracellular matrix, providing a favorable cellular environment. In this review, we summarize the recent developments in the preparation of dECM materials, including decellularization, crosslinking and sterilization. Also, we cover the advances in the utilization of dECM biomaterials in regeneration medicine in pre-clinic and clinical trials. Moreover, we highlight those emerging medical benefits of dECM beyond tissue engineering, such as cell transplantation, in vitro/in vivo model and therapeutic cues delivery. With the advances in the preparation and broader application, the dECM biomaterials could become the gold scaffold and pharmaceutical excipients in medical sciences.Keywords: Decellularization; Decellularized matrix biomaterials; Drug delivery; Tissue engineering; in vitro/vivo model
Mesh:
Substances:
Year: 2019 PMID: 31499951 DOI: 10.1016/j.msec.2019.109942
Source DB: PubMed Journal: Mater Sci Eng C Mater Biol Appl ISSN: 0928-4931 Impact factor: 7.328